A Genome-Wide Association Study Identifies UTRN Gene Polymorphism for Restless Legs Syndrome in a Korean Population
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Restless legs syndrome (RLS) is a highly heritable and common neurological sensorimotor disease disturbing sleep. The objective of study was to investigate significant gene for RLS by performing GWA and replication study in a Korean population. Methods: We performed a GWA study for RLS symptom group (n=325) and non-RLS group (n=2,603) from the Korea Genome Epidemiology Study. We subsequently performed a replication study in RLS and normal controls (227 RLS and 229 controls) to confirm the present GWA study findings as well as previous GWA study results. Results: In the initial GWA study of RLS, we observed an association of rs11645604 (OR=1.531, p=1.18×10-6) in MPHOSPH6 on chromosome 16q23.3, rs1918752 (OR=0.6582, p=1.93×10-6) and rs9390170 (OR=0.6778, p=7.67×10-6) in UTRN on chromosome 6q24. From the replication samples, we found rs9390170 in UTRN (p=0.036) and rs3923809 and rs9296249 in BTBD9 (p=0.045, p=0.046, respectively) were significantly associated with RLS. Moreover, we found the haplotype polymorphisms of rs9357271, rs3923809, and rs9296249 (overall p=5.69×10-18) in BTBD9 was associated with RLS. Conclusion: From our sequential GWA and replication study, we could hypothesize rs9390170 polymorphism in UTRN is a novel genetic marker for susceptibility to RLS. Regarding with utrophin, which is encoded by UTRN, is preferentially expressed in the neuromuscular synapse and myotendinous junctions, we speculate that utrophin is involved in RLS, particularly related to the neuromuscular aspects.
Abstract
Objective: Restless legs syndrome (RLS) is a highly heritable and common neurological sensorimotor disease disturbing sleep. The objective of study was to investigate significant gene for RLS by performing GWA and replication study in a Korean population. Methods: We performed a GWA study for RLS symptom group (n=325) and non-RLS group (n=2,603) from the Korea Genome Epidemiology Study. We subsequently performed a replication study in RLS and normal controls (227 RLS and 229 controls) to confirm the present GWA study findings as well as previous GWA study results. Results: In the initial GWA study of RLS, we observed an association of rs11645604 (OR=1.531, p=1.18×10-6) in MPHOSPH6 on chromosome 16q23.3, rs1918752 (OR=0.6582, p=1.93×10-6) and rs9390170 (OR=0.6778, p=7.67×10-6) in UTRN on chromosome 6q24. From the replication samples, we found rs9390170 in UTRN (p=0.036) and rs3923809 and rs9296249 in BTBD9 (p=0.045, p=0.046, respectively) were significantly associated with RLS. Moreover, we found the haplotype polymorphisms of rs9357271, rs3923809, and rs9296249 (overall p=5.69×10-18) in BTBD9 was associated with RLS. Conclusion: From our sequential GWA and replication study, we could hypothesize rs9390170 polymorphism in UTRN is a novel genetic marker for susceptibility to RLS. Regarding with utrophin, which is encoded by UTRN, is preferentially expressed in the neuromuscular synapse and myotendinous junctions, we speculate that utrophin is involved in RLS, particularly related to the neuromuscular aspects.
참고문헌 (40)
- Allen RP, "Restless legs syndrome", Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance, 2014, pp.15, 860~873
- Innes KE, "Prevalence of restless legs syndrome in North American and Western European populations : a systematic review", Sleep Med, 12, pp.623~634 (2011)
- Allen RP, "Restless legs syndrome prevalence and impact : REST general population study", Arch Intern Med, 165, pp.1286~1292 (2005)
- Connor JR, "Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome", Neurology, 62, pp.1563~1567 (2004)
- Trenkwalder C, "Restless legs syndrome: pathophysiology, clinical presentation and management", Nat Rev Neurol, 6, pp.337~346 (2010)
- Allen RP, "Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health", Sleep Med, 4, pp.101~119 (2003)
- Garcia-Borreguero D, "Cano-Pumarega I. New concepts in the management of restless legs syndrome", BMJ, 356, pp.j104~ (2017)
- Barriere G, "The restless legs syndrome", Prog Neurobiol, 77, pp.139~165 (2005)
- Whittom S, "Age-at-onset in restless legs syndrome : a clinical and polysomnographic study", Sleep Med, 9, pp.54~59 (2007)
- Winkelmann J, "Genetics of restless legs syndrome (RLS): state-of-the-art and future directions", Mov Disord, 22(suppl 18), pp.S449~S458 (2007)
- Chen S, "Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p", Am J Hum Genet, 74, pp.876~885 (2004)
- Allen RP., "Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome", Am J Med, 120, pp.S13~S21 (2007)
- Winkelmann J, "Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions", Nat Genet, 39, pp.1000~1006 (2007)
- Schormair B, "PTPRD(protein tyrosine phosphatase receptor type delta)is associated with restless legs syndrome", Nat Genet, 40, pp.946~948 (2008)
- Stefansson H, "A genetic risk factor for periodic limb movements in sleep", N Engl J Med, 357, pp.639~647 (2007)
- Winkelmann J, "Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1", PLoS Genet, 7, pp.e1002171~ (2011)
- Cho YS, "A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits", Nat Genet, 41, pp.527~534 (2009)
- Ban HJ, "Genetic and metabolic characterization of insomnia", PLoS One, 6, pp.e18455~ (2011)
- Howie BN, "A flexible and accurate genotype imputation method for the next generation of genome-wide association studies", PLoS Genet, 5, pp.e1000529~ (2009)
- Purcell S, "PLINK : a tool set for whole-genome association and populationbased linkage analyses", Am J Hum Genet, 81, pp.559~575 (2007)
- Huang da W, "Bioinformatics enrichment tools : paths toward the comprehensive functional analysis of large gene lists", Nucleic Acids Res, 37, pp.1~13 (2009)
- Huang da W, "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources", Nat Protoc, 4, pp.44~57 (2009)
- Pearce M, "The utrophin and dystrophin genes share similarities in genomic structure", Hum Mol Genet, 2, pp.1765~1772 (1993)
- Helliwell TR, "The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies", Neuromuscul Disord, 2, pp.177~184 (1992)
- Galvagni F, "The utrophin gene is transcriptionally up-regulated in regenerating muscle", J Biol Chem, 277, pp.19106~19113 (2002)
- Lukas Z., "The up-regulation of utrophin is not limited to muscular dystrophies", Gen Physiol Biophys, 18(Suppl 1), pp.87~89 (1999)
- Allen RP, "Restless legs syndrome : a review of clinical and pathophysiologic features", J Clin Neurophysiol, 18, pp.128~147 (2001)
- Wahlin-Larsson B, "The expression of vascular endothelial growth factor in skeletal muscle of patients with sleep disorders", Muscle Nerve, 40, pp.556~561 (2009)
- Blake DJ, "Function and genetics of dystrophin and dystrophin-related proteins in muscle", Physiol Rev, 82, pp.291~329 (2002)
- Haenggi T, "Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue", Cell Mol Life Sci, 63, pp.1614~1631 (2006)
- Wells KE, "Relocalization of neuronal nitric oxide synthase(nNOS)as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle", Neuromuscul Disord, 13, pp.21~31 (2003)
- Chaubourt E, "Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma : a possible compensation for dystrophin loss in duchenne muscular dystrophy", Neurobiol Dis, 6, pp.499~507 (1999)
- Prochniewicz E, "Dystrophin and utrophin have distinct effects on the structural dynamics of actin", Proc Natl Acad Sci U S A, 106, pp.7822~7827 (2009)
- Adams ME, "The alpha-syntrophin PH and PDZ domains scaffold acetylcholine receptors, utrophin, and neuronal nitric oxide synthase at the neuromuscular junction", J Neurosci, 30, pp.11004~11010 (2010)
- Winkelmann J, "Variants in the neuronal nitric oxide synthase (nNOS, NOS1)gene are associated with restless legs syndrome", Mov Disord, 23, pp.350~358 (2008)
- Jimenez-Jimenez FJ, "Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome", J Neural Transm (Vienna), 122, pp.819~823 (2015)
- Rife T, "The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson’s disease", J Neurosci Res, 87, pp.2319~2325 (2009)
- West AR, "Regulation of striatal dopamine neurotransmission by nitric oxide : effector pathways and signaling mechanisms", Synapse, 44, pp.227~245 (2002)
- Patton SM, "Hypoxia-inducible factor pathway activation in restless legs syndrome patients", Eur J Neurol, 18, pp.1329~1335 (2011)
- Ulfberg J, "Treatment of restless legs syndrome with a nitroglycerin patch", Sleep Med, 13, pp.1326~ (2012)
